The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Abstract
Four persons developed marked parkinsonism after using an illicit drug intravenously. Analysis of the substance injected by two of these patients revealed primarily 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) with trace amounts of 1-methyl-4-phenyl-4-propionoxy-piperidine (MPPP). On the basis of the striking parkinsonian features observed in our patients, and additional pathological data from one previously reported case, it is proposed that this chemical selectively damages cells in the substantia nigra.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most compelling evidence of mitochondrial dysfunction in PD comes from the accidental discovery of the synthetic meperidine analogue 1-methyl-4-phenyl-1,2,3,6-tetrahydrodropyridine (MPTP), which causes parkinsonism by selective inhibition of mitochondrial complex-I of the electron transport chain4, 5.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [4]
Citations
Cites
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377
GOLDSTEIN, J. E., & COGAN, D. G. (1965) · Archives of Ophthalmology · doi:10.1001/archopht.1965.00970030157003 · Cited by 129
PIPERIDINE DERIVATIVES. PART III. 4-ARYLPIPERIDINES1
Ziering, A., BERGER, L., HEINEMAN, S. D., et al. (1947) · The Journal of Organic Chemistry · doi:10.1021/jo01170a022 · Cited by 65
Cited by
Sorted by citations
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
Metadata
- Authors
- Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I.
- ORCID
- Ballard, Philip
- Venue
- Science
- Published
- 1983-02-25
- Volume
- 219
- Issue
- 4587
- Pages
- 979-980
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1969800514
- Cited by
- 4,914
- References
- 3
- Citations by year
- 2026: 54 · 2025: 73 · 2024: 88 · 2023: 105 · 2022: 120 · 2021: 126 · 2020: 156 · 2019: 116 · 2018: 135 · 2017: 149 · 2016: 104 · 2015: 121 · 2014: 131 · 2013: 146 · 2012: 151
- FWCI
- 122.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- parkinsonism, MPTP, intravenous drug use, substantia nigra, neurotoxicity, Parkinson's disease
- MeSH terms
- Adult, Female, Humans, Male, Meperidine, Opioid-Related Disorders, Parkinson Disease, Secondary, Substantia Nigra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
